Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06173778 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Semaglutide for Post-Smoking Cessation Weight Management

StatusRecruiting
PhasePhase 2
Started2024-04-23
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 22 months later Jul 1, 2026 → May 25, 2028
See other at-risk trials from The University of Texas Health Science Center, Houston

Amendment history

2026-09-22
Primary completion pushed: 2026-07-01 → 2028-05-25
Completion pushed: 2026-08-01 → 2028-06-25
2026-02-06
Study Status v3
Re-verified, no change to tracked fields
2024-12-09
Study Status, Contacts/Locations v2
Study sites1→2
2024-05-14
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2024-03-01→confirmed 2024-04-23
Study sitesdetails revised at 1 of 1 site
2023-12-07
Original filing
This trial will examine the effect of semaglutide 2.4mg on changes in body weight, body composition, and peripheral and central mechanisms that control appetite, satiety, and food intake in the context of smoking cessation.
Trial Details
NCT Number NCT06173778
Lead Sponsor The University of Texas Health Science Center, Houston
Conditions Obesity, Overweight, Cigarette Smoking
Enrollment 197 participants
Start Date 2024-04-23
Primary Completion 2028-05-25 (estimated)
Study Completion 2028-06-25 (estimated)
Updated on ClinicalTrials.gov 2026-09-21